Livozo
ProgramsHow it worksPricingScienceFAQ
Back to home
ProgramsHow it worksPricingScienceFAQBack home

Livozo legal

Telehealth Informed Consent

You will be asked to acknowledge this consent before a clinician reviews your intake. Please read it carefully.

Last updated
May 17, 2026
Effective
To be set on launch
Status
DRAFT — pending healthcare counsel review
Contents
  1. Purpose of this consent
  2. Patient and provider identity
  3. Nature of telehealth
  4. Risks of telehealth
  5. Benefits and alternatives
  6. Your rights
  7. Emergency and follow-up care
  8. Confidentiality
  9. No-recording statement
  10. Cost and insurance
  11. Supplemental consent: compounded GLP-1
  12. Withdrawing consent
  13. Acknowledgment

1. Purpose of this consent

This document explains how telehealth works through the Livozo platform, what its risks and benefits are, and what your rights are as a patient. Your signature at the bottom acknowledges that you have read and understood it and consent to receive care by telehealth from a clinician affiliated with {{PC_NAME}}.

2. Patient and provider identity

Before any visit, we will verify your identity using government-issued ID or other appropriate means. We will identify the clinician providing your care, the state(s) in which the clinician is licensed, and the clinician's credentials. You may decline to proceed with a specific clinician.

3. Nature of telehealth

Telehealth is the use of electronic communications (secure messaging, video, audio) to provide medical care when you and the clinician are in different locations. Visits through Livozo are primarily asynchronous— you submit an intake and the clinician reviews it and replies. Some visits may include synchronous video or phone. Telehealth does not include in-person physical examination.

4. Risks of telehealth

  • Limited physical examination. Some conditions cannot be diagnosed or treated without an in-person exam.
  • Technology limitations. Equipment may fail. Image or video quality may degrade. Messages may be delayed.
  • Privacy and security. Although we use industry-standard safeguards, no electronic transmission is perfectly secure. There is a small risk that information could be intercepted by an unauthorized party.
  • Possibility that telehealth is not appropriate for you. The clinician may determine that your condition requires in-person evaluation and may decline to treat you by telehealth.
  • Medication risks. Any prescribed medication has potential side effects, interactions, and contraindications. Compounded medications carry additional risks described in section 11 below.

5. Benefits and alternatives

Benefits of telehealth include access to a licensed clinician without the need to travel, faster review, and reduced cost in some cases. Alternatives include seeking in-person care from a primary care physician, an endocrinologist, an obesity-medicine specialist, an urgent care center, or an emergency department. We encourage you to maintain a relationship with a primary care provider.

6. Your rights

  • You may refuse telehealth and seek care in person without losing access to other services.
  • You may withdraw consent at any time without affecting your right to future care.
  • You may request that a different clinician provide your care, subject to availability.
  • You may receive copies of your medical records and request amendments.
  • You may file a complaint with us, with the state medical board, or with HHS without retaliation.

7. Emergency and follow-up care

Livozo does not provide emergency care. If you believe you are having a medical emergency, call 911 or go to the nearest emergency department. For non-emergency follow-up, you can send a secure message through the Livozo Platform. We aim to respond within one business day; complex questions may take longer. If symptoms are urgent and you cannot reach us, contact your primary care provider or an urgent care center.

8. Confidentiality

Information shared during a telehealth visit is protected by the same federal and state privacy laws that apply to in-person care, including HIPAA and (where applicable) CMIA. See the HIPAA Notice of Privacy Practices for details. Confidentiality may be limited in narrow circumstances permitted or required by law (e.g., mandatory reporting of abuse, court order).

9. No-recording statement

Visits will not be audio- or video-recorded by your clinician unless you are first notified and you agree. You may not record a visit without your clinician's consent.

10. Cost and insurance

Livozo is a cash-pay service. We do not bill commercial insurance, Medicare, or Medicaid. The price displayed at checkout is the price you pay for that order. HSA or FSA cards may be accepted at checkout depending on the payment method.

11. Supplemental consent: compounded GLP-1 medications

If your clinician determines that a compounded semaglutide or tirzepatide product is appropriate for you, you will be asked to provide a separate supplemental consent acknowledging the following:

  • Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality.
  • Compounded semaglutide and tirzepatide are not generic equivalents of, and are not interchangeable with, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®.
  • Compounded versions of these medications may only be prescribed when there is a clinical reason that the FDA-approved drug is not appropriate for you (such as a documented allergy to an inactive ingredient or a dose that is not commercially available).
  • Common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and fatigue. Serious risks include pancreatitis, gallbladder disease, kidney problems, hypoglycemia (especially with other diabetes medications), and possible thyroid C-cell tumors (boxed warning for branded GLP-1 drugs).
  • You will report side effects and any new medications or conditions to your Livozo clinician promptly.
  • Refunds for compounded medication are limited per our Refund Policy. Federal law generally prohibits the return of dispensed prescription medication.

12. Withdrawing consent

You may withdraw this consent at any time by emailing [email protected]. Withdrawal applies prospectively; it does not affect care already provided. You may continue to use the Platform for non-clinical purposes after withdrawing.

13. Acknowledgment

By clicking “I consent” on the Platform, you acknowledge that you have read this consent, your questions (if any) have been answered, and you agree to receive care by telehealth.

State-specific elements

State telehealth consent laws vary. California, Texas, Florida, New York, Colorado, and Louisiana have specific statutory elements. The launch checklist includes mapping consent variants to each operating state — counsel review required before publishing state variants.

Livozo

Care that meets you at home.

[email protected][email protected]

Livozo, Inc.
131 Continental Dr., Suite 305
Newark, DE 19713

Fast shippingDiscreet and tracked.

Clinician-ledIndependent review.

Clear pricingNo surprise add-ons.

Programs

PT-141 (sexual health)SermorelinNAD+GlutathioneGHK-Cu (skin & hair)Testosterone therapyMenopause careAll programs

Care

How it worksPricingScienceReviewsFAQLab reviewCheck eligibility

Company

ContactAboutCliniciansPartnersEmployersCareers

Pharmacy providers

Livozo works with state-licensed compounding pharmacies. Fulfillment, medication availability, and routing depend on signed partner agreements and clinician judgment. See our Pharmacy Providers Disclosure for details.

Red Rock Pharmacy

St. George, UT

503A compounding pharmacy

Backup partner

To be confirmed at launch

503B outsourcing facility

Lab partners

Quest Diagnostics / LabCorp

Where labs are ordered

Important medical and legal information

Livozo is a telehealth technology platform. Livozo is not a medical practice or a pharmacy and does not make prescribing decisions. All medical care is provided by independent, licensed clinicians. Pharmacy fulfillment is handled by state-licensed pharmacies. Livozo facilitates the connection between patients, clinicians, and pharmacies. This website is not medical advice and does not create a clinician-patient relationship.

Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality. Our peptide protocols — including PT-141, sermorelin, NAD+, glutathione, and GHK-Cu — are prescribed off-label and dispensed as compounded preparations made by state-licensed 503A pharmacies based on an individual prescription. They are not FDA-approved products. See our No FDA Approval and Compounded Medication disclosures.

Results vary. Outcomes depend on individual health factors, adherence, diet, exercise, and clinician judgment. Past results do not guarantee future outcomes. Testimonials are from real Livozo patients; photos may use models for privacy. See our Results Disclaimer.

State availability. Treatment availability is determined by state telehealth law, pharmacy licensure, and clinician scope. Some programs may not be offered in all states. Final eligibility is determined during clinical intake.

Terms & ConditionsPrivacy PolicyPrivacy PracticesRefund PolicyMedical ConsentBill of RightsPharmacy ProvidersCompounded MedicationNo FDA ApprovalResults DisclaimerFor California ResidentsDo Not Sell or Share My Personal Information

© 2026 Livozo, Inc. All rights reserved.

livozo.com